Bioxytran (BIXT) Invested Capital (2010 - 2026)
Bioxytran (BIXT) posted Invested Capital of $355598.0 for Q1 2026, down 10.13% sequentially from $395668.0 in Q4 2025, and up 640.83% YoY from $48000.0 in Q1 2025.
Bioxytran (BIXT) Invested Capital (2010 - 2026) Analysis & Trends
Bioxytran has reported Invested Capital for 15 years, with the latest figure at $355598.0 in Q1 2026.
- Quarterly Invested Capital rose 640.83% year-over-year to $355598.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 236.83% YoY) and the FY2025 annual result came in at $395668.0, up 64.12% from the prior year.
- Invested Capital slipped to $355598.0 in Q1 2026 per BIXT's latest filing, from $395668.0 in the prior quarter.
- Over five years, Invested Capital peaked at $541405.0 in Q3 2025 and troughed at $25000.0 in Q3 2023.
- A 4-year average of $169263.6 and a median of $70974.0 in 2024 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 1324.75% in 2025, down 34.34% in 2025.
- Over 4 years, Invested Capital stood at $25000.0 in 2023, then soared by 864.31% to $241078.0 in 2024, then soared by 64.12% to $395668.0 in 2025, then declined by 10.13% to $355598.0 in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $355598.0, $395668.0, and $541405.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - | 355,598.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,598.00 |
| Dec 31, 2025 | 395,668.00 |
| Sep 30, 2025 | 541,405.00 |
| Jun 30, 2025 | 48,070.00 |
| Mar 31, 2025 | 48,000.00 |
| Dec 31, 2024 | 241,078.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 70,974.00 |
| Mar 31, 2024 | 73,107.00 |
| Dec 31, 2023 | 25,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Mar 31, 2021 | 420,750.00 |
| Sep 30, 2020 | 8,115.00 |
| Jun 30, 2018 | 25,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Dec 31, 2017 | 5,000.00 |
| Sep 30, 2017 | 5,000.00 |
| Jun 30, 2017 | 5,000.00 |
| Mar 31, 2017 | 25,000.00 |
| Dec 31, 2016 | 25,000.00 |